A study of the oncolytic poliovirus PVSRIPO in models of immunocompetent glioma in combination with PD-1/PD-L1 blockade revealed the effects of the therapy on glioma-associated macrophages and microglia, contributing to immune suppression and tumor progression. The gene discussed is CD274; the disease is glioma.